Douglas Edward Williams Ph.D.
Net Worth
Last updated:
What is Douglas Edward Williams Ph.D. net worth?
The estimated net worth of Dr. Douglas Edward Williams Ph.D. is at least $1,742,325 as of 28 Mar 2023. He has earned $14,965 from insider trading and has received compensation worth at least $1,727,360 in Codiak BioSciences, Inc..
What is the salary of Douglas Edward Williams Ph.D.?
Dr. Douglas Edward Williams Ph.D. salary is $863,680 per year as Pres, Chief Executive Officer & Director in Codiak BioSciences, Inc..
How old is Douglas Edward Williams Ph.D.?
Dr. Douglas Edward Williams Ph.D. is 67 years old, born in 1958.
What stocks does Douglas Edward Williams Ph.D. currently own?
As insider, Dr. Douglas Edward Williams Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Codiak BioSciences, Inc. (CDAK) | Pres, Chief Executive Officer & Director | 7,655 | $0 | $0 |
What does Codiak BioSciences, Inc. do?
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Douglas Edward Williams Ph.D. insider trading
Codiak BioSciences, Inc.
Dr. Douglas Edward Williams Ph.D. has made 3 insider trades in 2023, according to the Form 4 filled with the SEC. Most recently he sold 41,667 units of CDAK stock worth $7,500 on 28 Mar 2023.
The largest trade he's ever made was exercising 41,667 units of CDAK stock on 28 Mar 2023. As of 28 Mar 2023 he still owns at least 7,655 units of CDAK stock.
Codiak BioSciences key executives
Codiak BioSciences, Inc. executives and other stock owners filed with the SEC:
- Dr. Douglas Edward Williams Ph.D. (67) Pres, Chief Executive Officer & Director
- Ms. Yalonda Howze (53) Executive Vice President, Chief Legal Officer, Chief Compliance Officer & Corporation Sec.